SJM The JM notches 36 Q1 2026 EPS beat but shares dip 127 in todays trading The quiet strength in Ameren AEE business model On the Radar 20260508 What Public PSAL auditor changes mean for investors The recurring revenue story behind Arc Tx ARCT Q1 2026 EPS Exceeds Expectations FCRS FutureCrest management lays out key industry merger targets in its latest quarterly earnings update Barclays iPath Series B SP 500 VIX ShortTerm Futures ETN VXX Volatility Pullback Signals Geopolitical Risk Pricing Amid Equity Rebound WT WisdomTree Q1 earnings top estimates as revenue climbs 154 but stock slides 178 The Science publication represents a critical milestone in Mercks enlicitide development program Several key points distinguish this achievement Impact BioMedical IBO CEO lays out novel drug pipeline priorities to drive longterm global market expansion Gilead Sciences GILD Valuation Implications of Expanded Kymera Therapeutics Collaboration and Kymeras FDA Fast Track Designation EP Empire reports Q3 2025 loss per share of 12 cents stock trades flat on no consensus earnings estimates What Middlesex MSEX customer metrics tell us about future growth Q1 2026 EPS Misses Estimates Snowflake Inc SNOW Valuation Disparity Widens Following GPT 55 Cortex AI Platform Integration PYPL PayPal Holdings gains 147 percent even as its Q4 2025 EPS lands 61 percent below analyst estimates Dow Inc DOW Poised for Market Share Gains and Margin Expansion Amid US Natural Gas Glut and Global Supply Crunch